Lead Antibody Selection
Lead Antibody Selection is a methodological framework in antibody screening that identifies the most promising candidate antibody based on predefined efficacy, specificity, and developability criteria for subsequent preclinical and clinical evaluation.
8
Publications
320
Citations
71
Authors
13
Institutions
Publications per year
2017–2026
6
Parents
8
Michael X. Henderson, Dustin J. Covell, Charlotte Hiu-Yan Chung et al. · Neurobiology of Disease · 2019 · 47 citations · Full text
Development of Siglec-9 Blocking Antibody to Enhance Anti-Tumor Immunity
Hyeree Choi, Michelle Ho, Opeyemi S. Adeniji et al. · Frontiers in Oncology · 2021 · 46 citations · Full text
Medicine, Immunology, Oncology +17
1–5 of 8
71
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 71
13
University of Pennsylvania
Philadelphia, United States
1 h-index
14 publications
658 citations
Rensselaer Polytechnic Institute
Troy, United States
1 h-index
7 publications
294 citations
University College Dublin
Dublin, Ireland
1 h-index
1 publications
41 citations

University of Georgia
Athens, United States
1 h-index
3 publications
99 citations
Los Alamos National Laboratory
Los Alamos, United States
1 h-index
3 publications
99 citations
The Wistar Institute
Philadelphia, United States
1 h-index
9 publications
414 citations
Dublin City University
Dublin, Ireland
1 h-index
2 publications
82 citations
University of Wisconsin–Madison
Madison, United States
1 h-index
3 publications
39 citations
1–8 of 13
PEDS · 2 publications · 75 citations
2
h-index
2 publications · 98 citations
2
h-index
1 publications · 46 citations
1
h-index
1 publications · 47 citations
1
h-index
1 publications · 13 citations
1
h-index
1–5